Search research articles
Contact Us
Filters
Showing results (31-40 of 43) with videos related to
Page
of 5
Sort By:
Biophysical Journal
|
November 3, 2019
Inactivation of Bacteria by γ-Irradiation to Investigate the Interaction with Antimicrobial Peptides
Wilmar Correa, Julius Brandenburg, Jochen Behrends, et al.
International Journal of Molecular Sciences
|
February 5, 2021
Anti-Infective and Anti-Inflammatory Mode of Action of Peptide 19-2.5
Lena Heinbockel, Günther Weindl, Wilmar Correa, et al.
The FEBS Journal
|
March 8, 2019
Antibacterial action of synthetic antilipopolysaccharide peptides (SALP) involves neutralization of both membrane-bound and free toxins
Wilmar Correa, Lena Heinbockel, Jochen Behrends, et al.
Plos One
|
July 22, 2015
Therapeutical Administration of Peptide Pep19-2.5 and Ibuprofen Reduces Inflammation and Prevents Lethal Sepsis
Lena Heinbockel, Sebastian Marwitz, Sergio Barcena Varela, et al.
Advances in Experimental Medicine and Biology
|
April 14, 2019
Synthetic Anti-lipopolysaccharide Peptides (SALPs) as Effective Inhibitors of Pathogen-Associated Molecular Patterns (PAMPs)
Wilmar Correa, Lena Heinbockel, Guillermo Martinez-de-Tejada, et al.
Experimental & Molecular Medicine
|
June 17, 2017
Coupling killing to neutralization: combined therapy with ceftriaxone/Pep19-2.5 counteracts sepsis in rabbits
Sergio Bárcena-Varela, Guillermo Martínez-de-Tejada, Lukas Martin, et al.
Innate Immunity
|
February 28, 2016
Enhancing actions of peptides derived from the γ-chain of fetal human hemoglobin on the immunostimulant activities of monophosphoryl lipid A
Artur J Ulmer, Yani Kaconis, Lena Heinbockel, et al.
Current Drug Targets
|
June 6, 2012
Bacterial cell wall compounds as promising targets of antimicrobial agents II. Immunological and clinical aspects
Tobias Schuerholz, Sabine Dömming, Mathias Hornef, et al.
Antimicrobial Agents and Chemotherapy
|
January 16, 2013
Preclinical investigations reveal the broad-spectrum neutralizing activity of peptide Pep19-2.5 on bacterial pathogenicity factors
Lena Heinbockel, Susana Sánchez-Gómez, Guillermo Martinez de Tejada, et al.
Current Drug Targets
|
June 6, 2012
Bacterial cell wall compounds as promising targets of antimicrobial agents I. Antimicrobial peptides and lipopolyamines
Guillermo Martínez de Tejada, Susana Sánchez-Gómez, Iosu Rázquin-Olazaran, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 43) with videos related to
Sort By:
Page
of 5
Biophysical Journal
|
November 3, 2019
Inactivation of Bacteria by γ-Irradiation to Investigate the Interaction with Antimicrobial Peptides
Wilmar Correa, Julius Brandenburg, Jochen Behrends, et al.
International Journal of Molecular Sciences
|
February 5, 2021
Anti-Infective and Anti-Inflammatory Mode of Action of Peptide 19-2.5
Lena Heinbockel, Günther Weindl, Wilmar Correa, et al.
The FEBS Journal
|
March 8, 2019
Antibacterial action of synthetic antilipopolysaccharide peptides (SALP) involves neutralization of both membrane-bound and free toxins
Wilmar Correa, Lena Heinbockel, Jochen Behrends, et al.
Plos One
|
July 22, 2015
Therapeutical Administration of Peptide Pep19-2.5 and Ibuprofen Reduces Inflammation and Prevents Lethal Sepsis
Lena Heinbockel, Sebastian Marwitz, Sergio Barcena Varela, et al.
Advances in Experimental Medicine and Biology
|
April 14, 2019
Synthetic Anti-lipopolysaccharide Peptides (SALPs) as Effective Inhibitors of Pathogen-Associated Molecular Patterns (PAMPs)
Wilmar Correa, Lena Heinbockel, Guillermo Martinez-de-Tejada, et al.
Experimental & Molecular Medicine
|
June 17, 2017
Coupling killing to neutralization: combined therapy with ceftriaxone/Pep19-2.5 counteracts sepsis in rabbits
Sergio Bárcena-Varela, Guillermo Martínez-de-Tejada, Lukas Martin, et al.
Innate Immunity
|
February 28, 2016
Enhancing actions of peptides derived from the γ-chain of fetal human hemoglobin on the immunostimulant activities of monophosphoryl lipid A
Artur J Ulmer, Yani Kaconis, Lena Heinbockel, et al.
Current Drug Targets
|
June 6, 2012
Bacterial cell wall compounds as promising targets of antimicrobial agents II. Immunological and clinical aspects
Tobias Schuerholz, Sabine Dömming, Mathias Hornef, et al.
Antimicrobial Agents and Chemotherapy
|
January 16, 2013
Preclinical investigations reveal the broad-spectrum neutralizing activity of peptide Pep19-2.5 on bacterial pathogenicity factors
Lena Heinbockel, Susana Sánchez-Gómez, Guillermo Martinez de Tejada, et al.
Current Drug Targets
|
June 6, 2012
Bacterial cell wall compounds as promising targets of antimicrobial agents I. Antimicrobial peptides and lipopolyamines
Guillermo Martínez de Tejada, Susana Sánchez-Gómez, Iosu Rázquin-Olazaran, et al.
Page
of 5